These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874 [TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786 [TBL] [Abstract][Full Text] [Related]
4. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108 [TBL] [Abstract][Full Text] [Related]
5. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. Rodriguez C; Patel AV; Calle EE; Jacob EJ; Thun MJ JAMA; 2001 Mar; 285(11):1460-5. PubMed ID: 11255422 [TBL] [Abstract][Full Text] [Related]
7. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001 [TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen. Hildebrand JS; Gapstur SM; Feigelson HS; Teras LR; Thun MJ; Patel AV Int J Cancer; 2010 Dec; 127(12):2928-35. PubMed ID: 21351271 [TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study. Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck A; Danforth KN; Park Y; Brinton LA Br J Cancer; 2012 Sep; 107(7):1181-7. PubMed ID: 22929888 [TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort. Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161 [TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818 [TBL] [Abstract][Full Text] [Related]
12. Risk of endometrial cancer following estrogen replacement with and without progestins. Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721 [TBL] [Abstract][Full Text] [Related]
13. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Ross RK; Paganini-Hill A; Wan PC; Pike MC J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382 [TBL] [Abstract][Full Text] [Related]
14. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort. Persson I; Yuen J; Bergkvist L; Schairer C Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404 [TBL] [Abstract][Full Text] [Related]
15. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105 [TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163 [TBL] [Abstract][Full Text] [Related]
17. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136 [TBL] [Abstract][Full Text] [Related]
18. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. Beral V; Reeves G; Bull D; Green J; J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of postmenopausal hormone use and ovarian cancer risk. Danforth KN; Tworoger SS; Hecht JL; Rosner BA; Colditz GA; Hankinson SE Br J Cancer; 2007 Jan; 96(1):151-6. PubMed ID: 17179984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]